SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 93 filers reported holding SAGE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,803,146 | -56.7% | 233,389 | -1.0% | 0.00% | -50.0% |
| Q2 2023 | $11,081,086 | +6.0% | 235,668 | -5.4% | 0.00% | 0.0% |
| Q1 2023 | $10,458,425 | +9.9% | 249,248 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $9,519,058 | -33.2% | 249,582 | -31.5% | 0.00% | -33.3% |
| Q3 2022 | $14,260,000 | +25.5% | 364,129 | +3.5% | 0.00% | 0.0% |
| Q2 2022 | $11,363,000 | -2.6% | 351,784 | -0.2% | 0.00% | +50.0% |
| Q1 2022 | $11,672,000 | -19.9% | 352,623 | +3.0% | 0.00% | -33.3% |
| Q4 2021 | $14,570,000 | +29.9% | 342,489 | +35.3% | 0.00% | +50.0% |
| Q3 2021 | $11,214,000 | -28.1% | 253,083 | -7.9% | 0.00% | -33.3% |
| Q2 2021 | $15,602,000 | +4.7% | 274,653 | +37.9% | 0.00% | 0.0% |
| Q1 2021 | $14,907,000 | -16.8% | 199,162 | -3.9% | 0.00% | -25.0% |
| Q4 2020 | $17,925,000 | +44.0% | 207,207 | +1.7% | 0.00% | +33.3% |
| Q3 2020 | $12,450,000 | +44.7% | 203,710 | -1.5% | 0.00% | +50.0% |
| Q2 2020 | $8,603,000 | +43.9% | 206,900 | -0.6% | 0.00% | 0.0% |
| Q1 2020 | $5,979,000 | -84.5% | 208,118 | -61.1% | 0.00% | -80.0% |
| Q4 2019 | $38,665,000 | -71.1% | 535,603 | -43.8% | 0.01% | -73.0% |
| Q3 2019 | $133,746,000 | -38.7% | 953,353 | -20.0% | 0.04% | -38.3% |
| Q2 2019 | $218,243,000 | -6.2% | 1,192,003 | -18.5% | 0.06% | -7.7% |
| Q1 2019 | $232,630,000 | +32.6% | 1,462,625 | -20.1% | 0.06% | +18.2% |
| Q4 2018 | $175,433,000 | -19.8% | 1,831,437 | +18.3% | 0.06% | -1.8% |
| Q3 2018 | $218,707,000 | -10.7% | 1,548,360 | -1.0% | 0.06% | -16.4% |
| Q2 2018 | $244,898,000 | +4.5% | 1,564,548 | +7.6% | 0.07% | +3.1% |
| Q1 2018 | $234,263,000 | -12.2% | 1,454,414 | -10.3% | 0.06% | -7.1% |
| Q4 2017 | $266,930,000 | +58.1% | 1,620,611 | -40.2% | 0.07% | +52.2% |
| Q3 2017 | $168,834,000 | +6.8% | 2,710,027 | +36.5% | 0.05% | +2.2% |
| Q2 2017 | $158,128,000 | +8.2% | 1,985,533 | -3.5% | 0.04% | +12.5% |
| Q1 2017 | $146,183,000 | +302.6% | 2,056,895 | +189.3% | 0.04% | +300.0% |
| Q4 2016 | $36,307,000 | +474.4% | 711,066 | +418.0% | 0.01% | +400.0% |
| Q3 2016 | $6,321,000 | +101.7% | 137,267 | +32.0% | 0.00% | +100.0% |
| Q2 2016 | $3,134,000 | +6.2% | 104,010 | +13.0% | 0.00% | 0.0% |
| Q1 2016 | $2,950,000 | -83.7% | 92,032 | -70.4% | 0.00% | -80.0% |
| Q4 2015 | $18,122,000 | +415.1% | 310,827 | +274.0% | 0.01% | +400.0% |
| Q3 2015 | $3,518,000 | -45.8% | 83,108 | -6.6% | 0.00% | -50.0% |
| Q2 2015 | $6,495,000 | +243.7% | 88,965 | +136.5% | 0.00% | – |
| Q1 2015 | $1,890,000 | +30.6% | 37,612 | -4.9% | 0.00% | – |
| Q4 2014 | $1,447,000 | +60.6% | 39,533 | +38.3% | 0.00% | – |
| Q3 2014 | $901,000 | – | 28,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |